Ertapenem
Complicated intra-abdominal infections, Complicated skin and skin structure infections, including diabetic foot infections..., Community-acquired pneumonia, Complicated urinary tract infections including pyelonephritis, Acute pelvic infections including postpartum endomyometritis, septic abortion and..., Prophylaxis of surgical site infection following elective colorectal surgery (adults)
Indications
- Complicated intra-abdominal infections
- Complicated skin and skin structure infections, including diabetic foot infections...
- Community-acquired pneumonia
- Complicated urinary tract infections including pyelonephritis
- Acute pelvic infections including postpartum endomyometritis, septic abortion and...
- Prophylaxis of surgical site infection following elective colorectal surgery (adults)
Adult dosing
- treatment: dose: 1; unit: g; route: IV/IM; interval: once a day; fixed: true; labelExcerpt: The dosage should be 1 gram once a day intravenously or intramuscularly.
- prophylaxis: dose: 1; unit: g; route: IV; interval: single dose 1 hour prior to surgery; fixed: true; labelExcerpt: 1 gram single dose given 1 hour prior to elective colorectal surgery.
Pediatric dosing
- treatment: dose: 15; unit: mg/kg; route: IV/IM; interval: twice daily; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; labelExcerpt: Patients 3 months to 12 years of age should be administered 15 mg/kg twice daily (not to exceed 1 g/day intravenously or intramuscularly.)
Renal adjustment
- severe: 500 mg daily; failure: 500 mg daily; hemodialysis: 500 mg daily + 150 mg supplement; note: Adjustment necessary if CrCl <=30 mL/min/1.73 m2. Supplementary dose recommended if given within 6 hours prior to hemodialysis. Label: "Adult patients with severe renal impairment (creatinine clearance ≤30 mL/min/1.73 m 2 ) and end-stage renal disease (creatinine clearance ≤10 mL/min/1.73 m 2 ) should receive 500 mg daily. A supplementary dose of 150 mg is recommended if ertapenem is administe"
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Hypersensitivity to any component or other drugs in the same class
- Anaphylactic reactions to beta-lactams
- Hypersensitivity to local anesthetics of the amide type (IM only)
Clinical pearls
- Do not mix or co-infuse with other medications or use dextrose-containing diluents.
- Monitor for seizures, particularly in patients with CNS disorders or compromised renal function.
- Concomitant use with valproic acid is generally not recommended as it reduces valproic acid levels.
- Verify patient history for hypersensitivity to penicillins, cephalosporins, or other beta-lactams.
Source and review
- DailyMed label (ertapenem sodium, Ertapenem), Set ID c4da28cb-6725-4fa1-a7b0-e84f408fb36b, effective 2026-11-02. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties